Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer

International Journal of Colorectal Disease

Volumn 27, Issue 3, 2012, Pages 287-298

  Kong, Ying ^a   Bai, Pei Song ^a   Nan, Ke Jun ^a   Sun, Hong ^a   Chen, Nan Zheng ^a   Qi, Xiao Gai ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Catenin; Colorectal cancer; Pleiotrophin; VEGF

Indexed keywords

BETA CATENIN; CELL SURFACE RECEPTOR; PLEIOTROPHIN; PROTEIN TYROSINE PHOSPHATASE RECEPTOR BETA; PROTEIN TYROSINE PHOSPHATASE RECEPTOR ZETA; UNCLASSIFIED DRUG; VASCULOTROPIN; CARRIER PROTEIN; CYTOKINE; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR VASCULARIZATION; ADENOCARCINOMA; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD; CELL STRAIN CACO 2; CHILD; COLON; COLON TUMOR; DRUG EFFECT; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOSPHORYLATION; RECTUM; RECTUM TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BETA CATENIN; CACO-2 CELLS; CARRIER PROTEINS; CHILD; COLON; COLONIC NEOPLASMS; CYTOKINES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RECTAL NEOPLASMS; RECTUM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84862592914     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1344-z     Document Type: Article

References (29)

1. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, Milbrandt J, Deuel TF (1990) Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250(4988):1690-1694
2. Polykratis A, Delbé J, Courty J, Papadimitriou E, Katsoris P (2004) Identification of Heparin affin regulation peptide domains with potential role on angiogenesis. Int J Biochen Cell Biol 36 (10):1954-1966
3. Chang Y, Zuka M, Perez-Pinera P, Astudillo A, Mortimer J, Berenson JR, Deuel TF (2007) Secretion of pleiotrophin stimulates breast cancer progression through remodeling of the tumor microenvironment. Proc Natl Acad Sci USA 104(26):10888-10893
4. Souttou B, Juhl H, Hackenbruck J, Röckseisen M, Klomp HJ, Raulais D, Vigny M, Wellstein A (1998) Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J Natl Cancer Inst 90(19):1468-1473
5. Calvet L, Geoerger B, Regairaz M, Opolon P, Machet L, Morizet J, Joseph JM, Elie N, Vassal G (2006) Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivityto irinotecan. Oncogene 25(22):3150-3159
6. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 55(18):3964-3968
7. Lee JC, Chow NH, Wang ST, Huang SM (2000) Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 36(6):748-753
8. Meng K, Rodriguez-Peña A, Dimitrov T, Chen W, Yamin M, Noda M, Deuel TF (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 97(6):2603-2608
9. Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K (2005) Glycogen-Synthase Kinase3beta/beta-catenin axis promotes an-giogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 96(3):308-318
10. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, Wiesmann M, Garcia PD, Fuller JH, Chan V, Randazzo F, Gundel R, Warren RS, Escobedo J, Aukerman SL, Taylor RN, Fantl WJ (2003) ß-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63(12):3145-3153
11. Héroult M, Bernard-Pierrot I, Delbé J, Hamma-Kourbali Y, Katsoris P, Barritault D, Papadimitriou E, Plouet J, Courty J (2004) Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF)and inhibits VEGF-induced angiogenesis. Oncogene 23(9):1745-1753
12. Gorreta F, Runfola TP, VanMeter AJ, Barzaghi D, Chandhoke V, Del Giacco L (2005) Identification of thioredoxin reductase 1-regulated genes using small interference RNA and cDNA micro-array. Cancer Biol Ther 4(10):1079-1088
13. Muramatsu T (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J Biochem 132(3):359-371
14. Yamakawa T, Kurosawa N, Kadomatsu K, Matsui T, Itoh K, Maeda N, Noda M, Muramatsu T (1999) Levels of expression of pleiotrophin and protein tyrosine phosphatasez are decreased in human colorectal cancers. Cancer Lett 135(1):91-96
15. Vacherot F, Delbé J, Heroult M, Barritault D, Fernig DG, Courty J (1999) Glycosaminoglycans differentially bind HARP and modulate its biological activity. J Biol Chem 274(12):7741-7747
16. Isemura M, Sato N, Munakata H, Aikawa J, Ototani N, Yosizawa Z, Sakuma A, Masuda T, Aoyagi Y, Ichida F (1984) Glycosami-noglycans of human colonic mucosa and colonic adenocarcinoma. Tohoku J Exp Med 142(1):89-95
17. Dai J, Rabie AB (2007) VEGF:an essential mediator of both angiogenesis and endochondral ossification. J Dent Res 86 (10):937-950
18. Vecchiarelli-Federico LM, Cervi D, Haeri M, Li Y, Nagy A, BenDavid Y (2010) Vascular endothelial growth factor-a positive and negative regulator of tumor growth. Cancer Res 70(3):863-867
19. Novotny WF, Maffi T, Mehta RL, Milner PG (1993) Identification of novel heparin-releasable proteins, as well as the cytokines midkine and pleiotrophin, in human postheparin plasma. Arte-rioscler Thromb 13(12):1798-1805
20. Polytarchou C, Hatziapostolou M, Papadimitriou E (2005) Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J Biol Chem 280(49):40428-40435
21. 2 sensing. J Biol Chem 275(33):25130-25138
22. Coothankandaswamy V, Liu Y, Mao SC, Morgan JB, Mahdi F, Jekabsons MB, Nagle DG, Zhou YD (2010) The alternative medicine pawpaw and its acetogenin constituents suppress tumor angiogenesis via the HIF-1/VEGF pathway. J Nat Prod 73 (5):956-961
23. Clark DE, Lord EA, Suttie JM (2006) Expression of VEGF and pleiotrophin in deer antler. Anat Rec A Discov Mol Cell Evol Biol 288(12):1281-1293
24. Perez-Pinera P, Zhang W, Chang Y, Vega JA, Deuel TF (2007) Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation. J Biol Chem 282(39):28683-28690
25. Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ (2001) Oncogenic mutants of RoN and MET receptor tyrosine kinases cause activation of the β-catenin pathway. Mol Cell Biol 21(17):5857-5868
26. Podar K, Anderson KC (2010) A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways. Cell Cycle 9 (9):1722-1728
27. Li G, Hu Y, Huo Y, Liu M, Freeman D, Gao J, Liu X, Wu DC, Wu H (2006) PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J Biol Chem 281(16):10663-10668
28. Gu D, Yu B, Zhao C, Ye W, Lv Q, Hua Z, Ma J, Zhang Y (2007) The effect of pleiotrophin signaling on adipogenesis. FEBS Lett 581(3):382-388
29. Tian Q, He XC, Hood L, Li L (2005) Bridging the BMP and Wnt pathways by PI3K/AKT and 14-3-3zeta. Cell Cycle 4(2):215-216